Sun Pharmaceutical Industries Limited
SUNPHARMA
Peringkat dalam Saham
#526
Sun Pharmaceutical Industries Limited, a leading generic pharmaceutical... Sun Pharmaceutical Industries Limited, a leading generic pharmaceutical enterprise, is dedicated to the research, development, production, and marketing of both proprietary and unbranded medicinal formulations, alongside active pharmaceutical ingredients (APIs), for distribution across India and international markets. Its extensive product range encompasses treatments for numerous therapeutic fields, including central nervous system disorders, dermatological conditions, cardiovascular diseases, oncology, ophthalmic care, neuropsychiatry, gastrointestinal issues, infectious diseases, diabetes management, pain relief, nutritional supplements, respiratory ailments, gynaecology, urology, orthopaedics, nephrology, and dental health, among others. The company additionally provides APIs crucial for the creation of anti-cancer drugs, peptides, steroids, sex hormones, and controlled substances. Its generic medications are available in various forms, such as tablets, capsules, injectables, inhalers, ointments, creams, and liquid preparations. Furthermore, Sun Pharma develops specialized medications and a variety of over-the-counter health products. The company was established in 1983 and operates from its headquarters in Mumbai, India.
Harga Saham
$19.24
Terakhir disinkronkan: 2026-10-19
Kapitalisasi Pasar
$46.15B
Perubahan (1 hari)
-0.97%
Perubahan (1 tahun)
0.11%
Negara
IN
Perdagangan Sun Pharmaceutical Industries Limited (SUNPHARMA)
Kategori
Healthcare
Jumlah saham beredar untuk Sun Pharmaceutical Industries Limited (SUNPHARMA)
Jumlah saham beredar per June 2026: 2.40B
Menurut laporan keuangan terbaru dan harga saham Sun Pharmaceutical Industries Limited, jumlah saham beredar saat ini adalah 2.40B. Pada akhir March 2024, perusahaan memiliki 2.40B saham beredar. Jumlah saham beredar biasanya dipengaruhi oleh pemecahan saham dan pembelian kembali saham.
Riwayat saham beredar untuk Sun Pharmaceutical Industries Limited (SUNPHARMA) dari 2004 hingga 2026
Saham beredar pada akhir setiap tahun
| Tahun | Saham Beredar | Mengubah |
|---|---|---|
| 2026 (TTM) | 2.40B | 0.11% |
| 2025 | 2.40B | -0.11% |
| 2024 | 2.40B | 0.00% |
| 2023 | 2.40B | 0.00% |
| 2022 | 2.40B | 0.00% |
| 2021 | 2.40B | 0.00% |
| 2020 | 2.40B | 0.00% |
| 2019 | 2.40B | 0.00% |
| 2018 | 2.40B | -0.17% |
| 2017 | 2.40B | -0.13% |
| 2016 | 2.41B | 0.06% |
| 2015 | 2.40B | 16.12% |
| 2014 | 2.07B | 0.00% |
| 2013 | 2.07B | 0.00% |
| 2012 | 2.07B | 0.00% |
| 2011 | 2.07B | 0.00% |
| 2010 | 2.07B | 0.00% |
| 2009 | 2.07B | 4.00% |
| 2008 | 1.99B | 5.99% |
| 2007 | 1.88B | 1.29% |
| 2006 | 1.86B | 0.00% |
| 2005 | 1.86B | 0.00% |
| 2004 | 1.86B | 0.00% |
Saham beredar untuk perusahaan serupa atau pesaing
| Perusahaan | Saham Beredar | Perbedaan | Negara |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| - | - |
CN
|
